Zobrazeno 1 - 10
of 1 535
pro vyhledávání: ''
Autor:
Paul Mitchell, G Rivalland, Hui Yu, Fred R. Hirsch, R. Mosher, L Churilov, K Asadi, Christopher J. Rivard, S Heynemann
Publikováno v:
Clinical Lung Cancer. 23:e90-e98
Background NaPi2b is a multi-transmembrane sodium-dependent phosphate transporter expressed at normal levels in several organs, including lung. High expression levels have been reported in various tumours including breast, thyroid, ovarian and non-sm
Autor:
Li Zhu, Shuning Ding, Ou Huang, Weiguo Chen, Yafen Li, Weilin Chen, Xiaosong Chen, Jiayi Wu, Mengdi Chen, Caijin Lin, Deyue Liu, Kunwei Shen, Lisa Andriani, Jianrong He
Publikováno v:
Clinical Breast Cancer. 22:e147-e156
BACKGROUND In human epidermal growth factor receptor 2 (HER2)-positive breast cancer, emerging evidence imply that clinical behaviors differ according to hormone receptor (HR) status. However, there is no conclusion about the relevance between estrog
A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer
Autor:
Mohammad Muhsin Chisti, Swechchha Silwal, Geetha Krishnamoorthy, Siddhartha Yadav, Sumeet Kumar Yadav
Publikováno v:
Clinical Breast Cancer. 22:161-169
Introduction Triple-negative breast cancer (TNBC) in men is very rare. The clinical characteristics, prognostic factors, and overall survival of men with TNBC have not been characterized. Methods The study population consisted of men and women with a
Autor:
Lindsey Hendrickson, Iya Znoyko, James Kalmuk, Daynna J. Wolff, Irl Brian Greenwell, Zane Chiad, Cynthia A. Schandl, Sandra Mazzoni, Nina D. Wagner-Johnston, Brian T. Hess
Publikováno v:
Cancer Genetics. :18-22
Richter transformation (RT) refers to the development of an aggressive lymphoma in patients with pre-existing chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). It carries a poor prognosis secondary to poor response to therapy or rapi
Autor:
Hao Wang, Qiaohua Xie, Cong Cheng, Peng Wang, Liping Lei, ShouZi Hu, Guofang Liu, Huabang Zhou, YouShun Liu, Heping Hu
Publikováno v:
Bulletin du Cancer. 108:931-939
Summary Background Both modified Child-Pugh (MCP) and Albumin-bilirubin (ALBI) grade were reported that simpler, more objective and evidence-based alternative to the Child-Pugh (CP) class for assessing liver function. Aims To investigate whether the
Autor:
Fei Ma, Yanxia Sun, Qing Li, Peng Yuan, Shanshan Chen, Jiayu Wang, Yang Luo, Ying Fan, Pei Yu, Binghe Xu, Yiqun Han, Ruigang Cai, Qiao Li, Pin Zhang
Publikováno v:
Clinical Breast Cancer. 21:e497-e505
Different clinicopathologic characteristics could contribute to inconsistent prognoses of small breast neoplasms (T1a/T1b). This study was done to conduct a retrospective analysis and establish a clinical prediction model to predict individual surviv
Autor:
Jonathan A. Ledermann, Rebecca Asher, Michael Friedlander, Ilan Bruchim, Sarah J. Lord, Eric Pujade-Lauraine, Ronnie Shapira-Frommer, Clare L. Scott, Ursula A. Matulonis, Amit M. Oza, Philipp Harter, Charlie Gourley, Tomasz Huzarski, Val Gebski, Angelina Tjokrowidjaja, Chee Khoon Lee, Ignace Vergote, Manuel Rodrigues, Werner Meier, Tsveta Milenkova
Publikováno v:
European Journal of Cancer. 154:190-200
Background The impact of maintenance therapy with PARP inhibitors (PARPi) on progression-free survival (PFS) in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer (PSROC) varies widely. Individual prognostic factors do not r
Publikováno v:
Lung Cancer. 158:47-54
Objectives As a poor prognostic factor, visceral pleural invasion (VPI) was incorporated into non-small cell lung cancer (NSCLC) staging system. For modifying the T description of NSCLC, the prognostic value of VPI was assessed. Materials and Methods
Autor:
Veronica Conca, Matteo Clavarezza, Chiara Cremolini, Alessandra Boccaccino, Filippo Pietrantonio, Roberto Moretto, Cristina Granetto, Gianluca Tomasello, Alessandro Bertolini, Antonio Frassoldati, Alfredo Falcone, Mirella Giordano, Alessandro Passardi, Sara Lonardi, Anello Marcello Poma, Gianluca Masi, Gabriella Fontanini, Clara Ugolini, Giuseppe Aprile, Marco Maria Germani
Publikováno v:
European Journal of Cancer. 153:16-26
Background Recent data from the TRIBE2 study have failed to suggest a higher magnitude of benefit from upfront FOLFOXIRI/bevacizumab in patients with BRAF-mutant metastatic colorectal cancer (mCRC) as previously reported in the TRIBE study. Patients
Autor:
Abdurrahman Aldiab, Ammar C. Al-Rikabi, Khalid Alsaleh, Nashwa Abd El-Aziz, Tareq Salah, Sufia Husain, Maria Arafah
Publikováno v:
Clinical Breast Cancer. 21:e362-e367
Progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) significantly influence disease prognosis and therapeutic response in patients with breast cancer. Neoadjuvant chemotherapy (NACT) can change the